About/Juvenile Diabetes Research Foundation/Chesapeake/Curing Type 1 Diabetes
Health Care & Social Assistance sector comprises firms providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with providing medical care exclusively, continuing with those providing health care and social assistance and finally finishing with only social assistance. The services provided in this sector are delivered by trained health practitioners and social workers with requisite experience. Type 1 diabetes (T1D) is an autoimmune disease in which a person’s pancreas stops producing insulin. It occurs when the body’s immune system attacks and destroys the insulin-producing cells in the pancreas, called beta cells. While its causes are not yet entirely understood, scientists believe that both genetic factors and environmental triggers are involved. Its onset has nothing to do with diet or lifestyle. There is nothing you can do to prevent T1D, and—at present—nothing you can do to get rid of it.
While people with T1D rely on insulin therapy to control their blood sugar, insulin is not a cure nor does it prevent the possibility of the disease’s serious side effects. Even with intensive disease management, a significant portion of their day is still spent with high or low blood-sugar levels, placing people with T1D at risk for devastating complications such as heart attack, stroke, blindness, kidney disease and amputation. Chesapeake is the second largest city by land area in Virginia. Chesapeake offers a unique blend of urban and rural settings, and was ranked as one of the country’s top 100 best places to live by Money Magazine. Chesapeake offers a high quality of life for those looking for fine homes, exceptional career opportunities, and great schools. Part of the Great Dismal Swamp National Wildlife Refuge, one of the largest protected wildlife areas on the east coast, lies in Chesapeake. Recreational boaters travel through Chesapeake from the Chesapeake Bay to Albemarle Sound in North Carolina via the Great Dismal Swamp Canal. JDRF was founded in the New York area. Led by Lee Ducat, a group of local parents of children with T1D mobilized to raise money for diabetes research, and formed the first chapter of what was then known as the Juvenile Diabetes Foundation. A second chapter was founded shortly thereafter in Miami, Florida, followed by chapters in northern New Jersey and Washington, D.C. The fledgling organization was defined by its commitment to research funding. In addition to the high priority on funding T1D research, the organization’s founders resolved to inform the public about all aspects of T1D, advocate for more research funding from the federal government, and maintain the organization’s system of management by volunteer lay people. Since its inception, JDRF has evolved to become a worldwide leader in the fight against T1D. JDRF now has chapters and branches in most U.S. states, and international affiliates in several different countries. See full list of Video Credits http://broadcaster.beazil.net/public/credits/youtube/videos/41437 JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
All in all, it was all about –
diabetes prevention program,TypeOneNation,Government Advocacy,young adult diabetes,glycemic control comparison,charity,50/50 insulin,World without T1D,Treatment Advocacy,Juvenile Diabetes,Novolin N,Regular Acting Insulin,Virginia,T1D Community,Insulin detemir,autoimmune therapies,Oral Glucose Tolerance Test,noninsulin treated patients,Nutrition,using insulin,Non-Profit Organization,hypoglycemic episodes,Clinicians,Greater Louisville Walk,sugar diabetes,Diabetes Complication,T1D,hyperglycemic crisis,Diabetes and Pregnancy,ketonuria,preventive therapies,Robert Wood Johnson IV,Weight Loss Support,T1D burden,Juvenile Diabetes charity,Neuropathy,secondary diabetes,First time with insulin pump,diabetes self-management education,Chapter Volunteer Outreach Chairs,volunteering,high blood glucose,glycemic targets,hypoglycemia,The Automation to Simulate Pancreatic Insulin Response Trial,Team Cure Diabetes,CGM,Environmental Triggers,Glucagon,get.